These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3125261)

  • 1. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.
    Ward DJ; Nutman TB; Zea-Flores G; Portocarrero C; Lujan A; Ottesen EA
    J Infect Dis; 1988 Mar; 157(3):536-43. PubMed ID: 3125261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to onchocerciasis: recognition of larval antigens by humans putatively immune to Onchocerca volvulus infection.
    Nutman TB; Steel C; Ward DJ; Zea-Flores G; Ottesen EA
    J Infect Dis; 1991 May; 163(5):1128-33. PubMed ID: 2019761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens.
    Boyer AE; Tsang VC; Eberhard ML; Zea-Flores G; Hightower A; Pilcher JB; Zea-Flores R; Zhou W; Reimer CB
    J Immunol; 1991 Jun; 146(11):4001-10. PubMed ID: 2033268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune responses in human infection with Onchocerca volvulus.
    Gallin M; Edmonds K; Ellner JJ; Erttmann KD; White AT; Newland HS; Taylor HR; Greene BM
    J Immunol; 1988 Mar; 140(6):1999-2007. PubMed ID: 3257994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of both IFN-gamma and IL-5 by Onchocerca volvulus S1 antigen-specific CD4+ T cells from putatively immune individuals.
    Doetze A; Erttmann KD; Gallin MY; Fleischer B; Hoerauf A
    Int Immunol; 1997 May; 9(5):721-9. PubMed ID: 9184917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis.
    Elkhalifa MY; Ghalib HW; Dafa'Alla T; Williams JF
    Clin Exp Immunol; 1991 Dec; 86(3):433-9. PubMed ID: 1747951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
    Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite antigens are present in breast milk of women infected with Onchocerca volvulus.
    Petralanda I; Yarzabal L; Piessens WF
    Am J Trop Med Hyg; 1988 Mar; 38(2):372-9. PubMed ID: 3354770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
    George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
    Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
    Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
    Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
    Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response.
    Cooper PJ; Mancero T; Espinel M; Sandoval C; Lovato R; Guderian RH; Nutman TB
    J Infect Dis; 2001 Jun; 183(11):1662-8. PubMed ID: 11343216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
    Cho-Ngwa F; Liu J; Lustigman S
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e800. PubMed ID: 20808763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in antibody profile after treatment of human onchocerciasis.
    Lee SJ; Francis HL; Awadzi K; Ottesen EA; Nutman TB
    J Infect Dis; 1990 Aug; 162(2):529-33. PubMed ID: 2197344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.
    Elson LH; Calvopiña M; Paredes W; Araujo E; Bradley JE; Guderian RH; Nutman TB
    J Infect Dis; 1995 Mar; 171(3):652-8. PubMed ID: 7876612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.